191 related articles for article (PubMed ID: 22520146)
41. Pituitary apoplexy: managing the life-threatening condition associated with pituitary adenomas.
Witek P
Minerva Endocrinol; 2014 Dec; 39(4):245-59. PubMed ID: 25069845
[TBL] [Abstract][Full Text] [Related]
42. [Pituitary carcinomas and aggressive adenomas: an overview and new therapeutic options].
Maïza JC; Caron P
Ann Endocrinol (Paris); 2009 Sep; 70 Suppl 1():S12-9. PubMed ID: 19878763
[TBL] [Abstract][Full Text] [Related]
43. [Effects of irradiation therapy and inhibiting drugs on the pituitary and its adenomas].
Saeger W
Pathologe; 2006 Feb; 27(1):57-60. PubMed ID: 16362259
[TBL] [Abstract][Full Text] [Related]
44. Use of temozolomide in aggressive pituitary tumors: case report.
Mohammed S; Kovacs K; Mason W; Smyth H; Cusimano MD
Neurosurgery; 2009 Apr; 64(4):E773-4; discussion E774. PubMed ID: 19349807
[TBL] [Abstract][Full Text] [Related]
45. [Pituitary apoplexy due to macroadenoma bleeding].
Valle Feijoo ML; Fernández Fernández FJ; Muñoz López F; de la Fuente Aguado J
Endocrinol Nutr; 2011; 58(6):317-8. PubMed ID: 21497570
[No Abstract] [Full Text] [Related]
46. [Treatment of clinically nonfunctioning pituitary adenomas].
Alameda Hernando C; Lahera Vargas M; Varela Da Costa C
Endocrinol Nutr; 2010 Feb; 57(2):71-81. PubMed ID: 20227355
[TBL] [Abstract][Full Text] [Related]
47. Therapeutic innovations in endocrine diseases - part 3 : temozolomide and future therapeutics for aggressive pituitary tumors and carcinomas.
Lasolle H; Raverot G
Presse Med; 2016 Jun; 45(6 Pt 2):e211-6. PubMed ID: 27242211
[TBL] [Abstract][Full Text] [Related]
48. Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases.
Losa M; Mazza E; Terreni MR; McCormack A; Gill AJ; Motta M; Cangi MG; Talarico A; Mortini P; Reni M
Eur J Endocrinol; 2010 Dec; 163(6):843-51. PubMed ID: 20870708
[TBL] [Abstract][Full Text] [Related]
49. Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasm.
Syro LV; Uribe H; Penagos LC; Ortiz LD; Fadul CE; Horvath E; Kovacs K
Clin Endocrinol (Oxf); 2006 Oct; 65(4):552-3. PubMed ID: 16984254
[No Abstract] [Full Text] [Related]
50. [Tumoral pituitary apoplexy and cocaine consumption].
Ramos-Zúñiga R; Hasslacher-Arellano F; González-Jara G; Gómez-Ríos D; Vázquez-Moreno J; Camarena-Pérez H
Rev Neurol; 2009 Jan 16-31; 48(2):107-8. PubMed ID: 19173209
[No Abstract] [Full Text] [Related]
51. Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome.
Langsenlehner T; Stiegler C; Quehenberger F; Feigl GC; Jakse G; Mokry M; Langsenlehner U; Kapp KS; Mayer R
Strahlenther Onkol; 2007 May; 183(5):241-7. PubMed ID: 17497095
[TBL] [Abstract][Full Text] [Related]
52. Dopamine agonist-resistant prolactinomas.
Oh MC; Aghi MK
J Neurosurg; 2011 May; 114(5):1369-79. PubMed ID: 21214334
[TBL] [Abstract][Full Text] [Related]
53. Aggressive and malignant prolactin pituitary tumors: pathological diagnosis and patient management.
Zemmoura I; Wierinckx A; Vasiljevic A; Jan M; Trouillas J; François P
Pituitary; 2013 Dec; 16(4):515-22. PubMed ID: 23184261
[TBL] [Abstract][Full Text] [Related]
54. [Prolactin producing hypophyseal carcinoma. Case report of an extremely rare metastatic tumor].
Saeger W; Bosse U; Pfingst E; Schierke G; Kulinna H; Atkins D; Gullotta F
Pathologe; 1995 Sep; 16(5):354-8. PubMed ID: 7479609
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic evaluation of hyperprolactinemia.
Biller BM
J Reprod Med; 1999 Dec; 44(12 Suppl):1095-9. PubMed ID: 10649817
[TBL] [Abstract][Full Text] [Related]
56. Temozolomide for corticotroph pituitary adenomas refractory to standard therapy.
Dillard TH; Gultekin SH; Delashaw JB; Yedinak CG; Neuwelt EA; Fleseriu M
Pituitary; 2011 Mar; 14(1):80-91. PubMed ID: 20972839
[TBL] [Abstract][Full Text] [Related]
57. Anejaculation as the presenting feature of pituitary microadenoma.
Nair S; Milsom S
Fertil Steril; 2008 Nov; 90(5):2012.e21-3. PubMed ID: 18394608
[TBL] [Abstract][Full Text] [Related]
58. [New etiopathogenic, clinical and therapeutic findings in multiple endocrine neoplasia type 1].
Tomassetti P; De Giorgio R; Bosoni D; Del Vecchio E; Migliori M; Stanghellini V; Corinaldesi R
Minerva Gastroenterol Dietol; 1996 Sep; 42(3):133-43. PubMed ID: 8924487
[TBL] [Abstract][Full Text] [Related]
59. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
60. Secondary infertility as early symptom in a man with multiple endocrine neoplasia-type 1.
Schuppe HC; Neumann NJ; Schock-Skasa G; Höppner W; Feldkamp J
Hum Reprod; 1999 Jan; 14(1):252-4. PubMed ID: 10374130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
